You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,689.5% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -2.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 70.2 | 0.0 |
| Price / Book value | 1.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 36.4% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | n/a | -3.64 | -4.13p | -5.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-03-31 | n/a | -3.03 | -3.23p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-03-31 | n/a | -3.12 | -2.70p | -7.1 | 0.0 | n/a | n/a | 0.0% |
| 2020-03-31 | n/a | -3.17 | -2.07p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-03-31 | 0.19 | -3.21 | -1.82p | -4.1 | 0.0 | n/a | n/a | 0.0% |
| Evgen agrees fresh licensing deal with Spanish institutions Sharecast News | 18 Jan |
|---|---|
| Evgen pleased with preclinical data on SFX-01 Sharecast News | 13 Jul |
| Evgen 'surprised and disappointed' by findings in SFX-01 trial Sharecast News | 09 Jul |
| Option over new sulforaphane analogues | 18-Jan-22 07:00 |
|---|---|
| Progress with UK and US regulators for 2022 trials | 11-Jan-22 07:00 |
| Holding(s) in Company | 30-Dec-21 11:35 |
| Grant of Options | 08-Dec-21 14:09 |
| Half-year Report | 07-Dec-21 07:00 |